Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-07-13
1996-09-24
Fan, Jane
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546321, C07D21186, A61K 31455
Patent
active
055591396
ABSTRACT:
The invention relates to the new dimethyl 4-(4-chloro-3-trifluoromethylphenyl) -1-cyclopropyl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, a process for its preparation and its use as a medicament in ischaemic diseases which are associated with disorders of the microcirculation. This action can occur both in the peripheral and in the cerebral vascular system.
REFERENCES:
patent: 3773773 (1973-11-01), Bossert
patent: 3883543 (1975-05-01), Bossert
patent: 3956341 (1976-05-01), Loev
patent: 4780538 (1988-10-01), Pitzenberger et al.
patent: 4975440 (1990-12-01), Flockerzi et al.
patent: 5234935 (1993-08-01), Behner et al.
patent: 5342847 (1995-08-01), Behner et al.
patent: 5432185 (1995-07-01), Behner et al.
Behner Otto
Goldmann Siegfried
Rosen Bruno
Wollweber Hartmund
Zaiss Siegfried
Bayer Aktiengesellschaft
Fan Jane
LandOfFree
Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester, and it does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester, and it, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester, and it will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1928710